FDA
approval
· 2014-09-21
FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)
Summary
FDA approves Ascend Laboratories' supplemental application for amlodipine besylate (a generic calcium channel blocker) as an additional approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)